Losartan Potassium/Chlorthalidone

氯沙坦钾/氯噻酮

Report date: 2022/07/04 19:38:02

Base Information

Drug NameLosartan Potassium/Chlorthalidone
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsThiazide-sensitive sodium-chloride cotransporter inhibitors
TargetsAngiotensin II Receptor Type 1Thiazide-sensitive sodium-chloride cotransporter
Therapy Area/IndicationsEssential Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMexico
CombinationsYes Losartan PotassiumChlorthalidone
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesLaboratorios Silanes Sa De Cv
China Registration ClassN/A

Develop Information

Active CompaniesLaboratorios Silanes Sa De Cv
Inactive CompaniesN/A
Active IndicationsEssential Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A